Global Biodefense – 20 February 2020


In This Edition

Senators Call on Trump Administration to Immediately Fill Global Health Security Position

U.S. Senator Brian Schatz (D-Hawai‘i) and 26 of his Senate colleagues called on National Security Advisor Robert O’Brien in a Feb. 18 letter to appoint…

Why It’s Important to Study Coronaviruses in African Bats

The current outbreak of a new coronavirus disease, named COVID-19, raises the question of where diseases like this come from and where the risks lie.…

Rep. Chip Roy Letter to Trump Admin Seeks Answers on COVID-19 Risks to Joint Base San Antonio Community

As a member of Congress representing large portions of San Antonio, including Joint Base San Antonio, Representative Chip Roy sent a letter on Feb. 18…

HHS and Sanofi Join Forces on Recombinant Technology for COVID-19 Vaccine

Racing to develop a vaccine against the 2019 novel coronavirus, the U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness…

J&J to Expand Partnership with HHS to Accelerate Discovery of COVID-19 Therapeutics

Johnson & Johnson today announced that its Janssen Pharmaceutical Companies will expand its existing partnership with the Biomedical Advanced Research and Development Authority (BARDA), part…

Lassa Fever: Why There’s a Call to Declare a Health Emergency in Nigeria

The Nigerian Academy of Science has called for the current outbreak of Lassa fever in Africa’s most populous nation to be declared a national health…

Senator Murray Leads 25 Senate Democrats In Pressing Trump Administration to Request Emergency Funding for Novel Coronavirus Response

U.S. Senator Patty Murray (D-WA), a senior member of the Senate Appropriations Committee and the top Democrat on the Senate health committee, along with 25…

Coronavirus Outbreak Puts ‘Open Science’ Under a Microscope

As health authorities isolate the sick, set up quarantines and close borders, early efforts to stop a coronavirus pandemic are also trying something completely different:…

Expert Recommendations for US and Global Preparedness for COVID-19

The novel coronavirus outbreak that emerged in late 2019 has infected tens of thousands in China, community transmission is feared in other countries, and containment…

Remdesivir Prevents MERS Coronavirus Disease in Monkeys

The experimental antiviral remdesivir successfully prevented disease in rhesus macaques infected with Middle East respiratory syndrome coronavirus (MERS-CoV), according to a new study from National…

NIAID Makes New Images of SARS-CoV-2 Available for COVID-19 Coverage

The National Institute of Allergy and Infectious Diseases’ Rocky Mountain Laboratories (RML) has produced images of the novel coronavirus (SARS-CoV-2, previously known as 2019-nCoV), the…

There’s No Evidence the New Coronavirus Spreads Through the Air – But It’s Still Possible

A recent announcement by a Chinese health official suggested the new coronavirus might spread more easily than we thought, via an “airborne route”. The virus…

Medicare, Medicaid System Assigns Unique COVID-19 Lab Billing Code

The Centers for Medicare & Medicaid Services (CMS) took further action to ensure America’s healthcare facilities and clinical laboratories are prepared to respond to the threat…

CDC Update: Failed Roll-out of Diagnostic Due to Faulty Reagent; Sample Prioritization Mishap Delayed COVID-19 Diagnosis

The U.S. Centers for Disease Control and Prevention hosted its most recent 2019 novel coronavirus response update call on February 12. Dr. Nancy Messonnier, Director…

Re-Creating Live-Animal Markets in the Lab Lets Researchers See How Pathogens Jump Species

Nobody yet knows for sure the definitive origins of the newly recognized coronavirus now known as SARS-CoV-2 that’s currently spreading across the globe as a…

New Mapping Tool Lets You Scroll Through COVID-19 Coronavirus Outbreak Timeline

In the final weeks of 2019, a virus slipped furtively from animal to human somewhere in the Chinese city of Wuhan. This inauspicious moment marked…

The Silent Threat of COVID-19: America’s Dependence on Chinese Pharmaceuticals

As the new coronavirus, called COVID-19, spreads rapidly around the globe, the international community is scrambling to keep up. Scientists rush to develop a vaccine,…

WHO Names Disease Caused by New Coronavirus: COVID-19

WHO locks down a naming convention for the disease caused by novel coronaviruses. As for the virus itself (2019-nCoV), the International Committee on Taxonomy of…

Army Medical Department Board Tests Nerve Agent Antidote Auto-Injectors

Nerve agents are the most toxic of the known chemical agents. They are hazards in both liquid and vapor states and can cause death within…

Amid Coronavirus Outbreak, Leahy and Others Press Trump Administration to Fully Fund Pandemic Preparedness

Senator Patrick Leahy (D-VT) and three other senators Friday urged the Trump Administration to fully fund pandemic preparedness and response efforts in light of the…


Visit our new resource page for the novel coronavirus outbreak:


Headline News

Experts Say Cruise Ship Quarantine Pointless, Unjustified and Violates Human Rights

The Legal Mess of Coronavirus Quarantine Across America’s 2,500+ Public Health Departments

Ebola Still Constitutes a Public Health Emergency of International Concern

WHO Director Fights to Prevent a Pandemic Without Offending China

The U.S. Has a Biodefense Strategy. It Just Isn’t Following It.

China Launches Dozens of Clinical Trials to Identify Most Promising Treatments for COVID-19

Why Do Some of the Outbreak Genomes Have More Mutations Than Others?

Scientists Test Drugs Against Virus Samples from First U.S. COVID-19 Patient

Masks vs. Respirators: Experts Explain COVID-19 Recommendations

Coronavirus Disease Naming Announcement Creates Confusion

We Must Protect the Frontline Warriors Against COVID-19 by Ensuring Health Care Workers Have Necessary PPE

COVID-19 Hot Spots: Handful of Buildings Outside Wuhan Linked to Multiple Cases

Easy Diagnostic Tops Priorities at WHO COVID-19 Research Meeting

Coronavirus Epidemic Reaches Bleak Milestone, Exceeding SARS Toll

What Does the Illegal Wildlife Trade Have to Do With Spreading Epidemics?

Life and Death in a Wuhan Coronavirus ICU

Wuhan Coronavirus Outbreak Suggests We Aren’t Ready for a Pandemic

WHO Asks for $675 Million in Q1 to Stop Coronavirus Epidemic


Biosecurity + Biodefense Jobs

Biologist – HHS/ASPR/BARDA

This position is located in the Department of Health And Human Services, Office of the Secretary of Health and Human Services, Office of Biomedical Advanced Research and…

Technical Reachback Epidemiologist

Description Applied Research Associates, Inc. has an immediate opportunity for an epidemiologist to provide subject matter expert advice and decision support to the Defense Threat Reduction Agency…

Epidemic Intelligence Service Fellowship Class of 2021

EIS is a highly competitive, 2-year post-graduate fellowship in applied epidemiology. This CDC program, established in 1951, is a unique combination of on-the-job-learning and service. Investigating outbreaks…

Evaluation Specialist, Neglected Tropical Diseases

The Evaluation Specialist will provide qualitative, quantitative, and mixed methods guidance for evaluation and implementation research activities for RTI’s neglected tropical disease programming (including, primarily, the USAID-funded…

Deputy Director – Ebola Response Operations

The Deputy Director, Operations- Ebola Response (DDO) oversees the country program’s critical support functions: administration, human resources, supply chain and security, ensuring that all the necessary systems, policies…

Associate Program Officer, Polio, Eastern Mediterranean Region

As a key member of the Polio EMR (Eastern Mediterranean Region) team, the Associate Program Officer (APO), will partner closely with the Deputy Director (DD), EMR to…

Program Officer, Novel Coronavirus Response

The COVID-19 Response team was formed to organize and execute an investment strategy for the foundation’s comprehensive $100M response towards containment and mitigation of the COVID-19 novel…

Program Manager, Novel Coronavirus Response

The COVID-19 Response team was formed to organize and execute an investment strategy for the foundation’s comprehensive $100M response towards containment and mitigation of the COVID-19 novel…

Associate Strategy Officer, Novel Coronavirus Response

The COVID-19 Response team was formed to organize and execute an investment strategy for the foundation’s comprehensive $100M response towards containment and mitigation of the COVID-19 novel…

Senior Diagnostic and Health Security Advisor

The Senior Diagnostic and Health Security Advisor (SDHSA) will provide leadership, and technical oversight to support implementation of diagnostics systems capacity building work for an anticipated  CDC…

VIEW ALL CAREER OPPORTUNITIES


SOCMED Highlights


Failure to adequately fund the World Health Organization response to PHEICs (COVID-19 and Ebola)
On changing case definitions for COVID-19 in China
On ‘asymptomatic’ transmission, chronic and latent infection in the COVID-19 discourse

ADVERTISEMENT

Joint Civil & DoD CBRN Symposium

18-19 MARCH 2020

  • Driving Medical Countermeasures Development to Limit the Adverse Health Effects of CBRN Incidents
  • Modernizing Capabilities for Rapid and Accurate Threat Detection + Assessment
  • Supporting Enhanced Warfighter and Emergency Personnel Protection

LEARN MORE + REGISTER >>


Contracts, Grants + Innovation Challenges

Canadian 2019 Novel Coronavirus (2019-nCoV) Rapid Research Funding

The Government of Canada is launching a special funding call for a rapid research response to contribute to global efforts to contain the 2019 Novel Coronavirus outbreak.…

CDC Expedites Request Process Public Health Emergency Preparedness (PHEP) Cooperative Agreement Funds during COVID-19 Response

CDC has reduced the normal 30-day request process to one to three business days for urgent requests. The Division of State and Local Readiness (DSLR) has partnered…

Feb 28: NIAID BAA Proposals Due Advanced Development of Vaccine Candidates for Acute Flaccid Myelitis (AFM) Associated with Enterovirus D68

Mar 31: EZ BAA Deadline: Novel Coronavirus Rapid Diagnostic Concise abstract submissions due for BARDA development funding of SARS-CoV-2 molecular diagnostics.

Apr 6: Influenza Data Processing and Outreach Contract proposals due for the Influenza Data Processing and Communication Center (iDPCC).

Apr 9: Radiation/Nuclear Medical Countermeasures Development Supports MCMs to mitigate and/or treat tissue injuries resulting from exposure to ionizing radiation

Apr 9: Therapeutic Products for Biodefense, AMR Infections, and Emerging Infectious Diseases Supports development of promising new therapeutics to address infections caused by NIAID Category A, B, and C priority pathogens and select bacterial and fungal infections.

Apr 9: Advanced Development of Diagnostics for Biothreats and EID BAA topic supports development of novel, rapid sample-to-answer candidate diagnostic products that will address biodefense and pandemic preparedness.

Jul 2: NIBIB Technology Accelerator Challenge: Handheld Diagnostics Anticipated to be released this month, this innovation competition will spur design and development of non-invasive, handheld, digital diagnostic devices that will target anemia, sickle cell disease, malaria, and other blood-related diseases.

Pharmaceutical Cargo Security Initiative Health Care Supply Chain Survey The purpose of this survey is to gather information from pharmaceutical owners and operators regarding the coronavirus outbreak, including concerns and challenges.

Partners + Industry News

FDA Grants Soligenix “Fast Track” Designation for RiVax® in the Prevention of Ricin Poisoning

Soligenix, Inc. announced on Feb. 13 that its RiVax® (heat stable ricin toxin vaccine) development program for prevention of ricin intoxication has received “Fast Track” designation from the…

New Technology May Significantly Reduce Diagnostic Time of Coronavirus

Based on a combination of optics and magnetic particles 100 samples of patients potentially infected with the virus can rapidly be tested and diagnosed in approximately 15…

Emory, Collaborators Testing Antiviral Drug as Potential Treatment for Coronaviruses

The drug EIDD-1931 was effective against SARS and MERS viruses in the laboratory, and a modified version (EIDD-2801) could potentially be valuable against 2019-nCoV. An antiviral compound…

The Native Antigen Company Introduces Novel Coronavirus Antigens

Newly developed recombinant antigens derived specifically from 2019-nCoV for use in infectious disease research, and assay and vaccine development The Native Antigen Company, one of the world’s…

Scientists from Noblis and DoD Identify Unique Genetic Sequences of Emerging Coronavirus Threat

Scientists from Noblis and the Defense Biological Product Assurance Office (DBPAO), a component of the Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO-CBRND),…

Vir Biotechnology Identifies Two Antibodies That Bind to the Spike Protein of SARS-CoV-2

Vir Biotechnology, Inc., a clinical-stage immunology company focused on immune approaches to treating and preventing serious infectious diseases, today announced that it has identified two monoclonal antibodies (mAbs)…

HHS, Janssen Join Forces On Coronavirus Vaccine

To expedite development of vaccines that protect against the Coronavirus Disease COVID-19 caused by the SARS-CoV-2 virus, the U.S. Department of Health and Human Services’ Office of…

Spero Therapeutics Announces Exercise of $15.9 Million Option by BARDA for Tebipenem HBr Development

Spero Therapeutics, Inc., a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing treatments in high unmet need areas involving multi-drug resistant (MDR) bacterial infections and rare diseases, announced…

View All Industry Newswire

Headlines

Experts Say Cruise Ship Quarantine Pointless, Unjustified and Violates Human Rights

The Diamond Princess cruise ship has been host to the largest number of diagnosed COVID-19 cases outside China, with at least 621.  Public health and bioethics experts caution that such strict quarantines aren’t the best way to contain viruses like the novel COVID-19, and that letting people self-monitor their symptoms at home is a more […]

The Legal Mess of Coronavirus Quarantine Across America’s 2,500+ Public Health Departments

America’s defense against epidemics is divided among 2,684 state, local, and tribal public-health departments. The federal government’s quarantine powers at U.S. borders are extensive. Travel ban on noncitizens who have been anywhere in China recently have been enacted, and the Secretary of Health and Human Services announced quarantine measures for returning citizens not long after […]

Ebola Still Constitutes a Public Health Emergency of International Concern

The second-biggest Ebola outbreak in history, which has upended life in eastern Congo’s North Kivu and Ituri provinces since August 2018, infecting nearly 3,500 people and killing about 2,250, is down to its last chain of transmission. Despite ongoing violence that has hampered the response from its outset, and that has spiked again recently, new […]

WHO Director Fights to Prevent a Pandemic Without Offending China

If Tedros wants WHO to stay informed about what’s happening in China and influence how the country handles the epidemic, he cannot afford to antagonize the notoriously touchy Chinese government—even though it is clear the country has been less than fully transparent about the outbreak’s early stages, and perhaps still is. Critics say that stance […]

The U.S. Has a Biodefense Strategy. It Just Isn’t Following It.

The US has a biodefense strategy—it just isn’t following it. In 2018, the Trump administration released a National Biodefense Strategy which was supposed to help coordinate government-wide efforts like detecting and responding to diseases. Asha George, a biosecurity expert and member of the Bulletin of the Atomic Scientists’ Science and Security Board, says the implementation […]

China Launches Dozens of Clinical Trials to Identify Most Promising Treatments for COVID-19

A randomized, controlled trial is the gold standard of clinical research. But pulling one together for Covid-19 is complicated by the realities of working in hospital systems overwhelmed by the sheer size of the outbreak. One of the biggest issues is ensuring the same standard of care in every place where the drug is being […]

Why Do Some of the Outbreak Genomes Have More Mutations Than Others?

Recent news reports have included speculation that the SARS-CoV-2 virus is ‘mutating’ and ‘evolving’ amid increasing concern that the outbreak could present an even more significant threat than it does already. At present there is no evidence to think that this is the case. Don’t be scared of mutation. Mutations happen all the time at […]

Scientists Test Drugs Against Virus Samples from First U.S. COVID-19 Patient

Virologist Matthew Frieman at the University of Maryland School of Medicine is just one of the scientists cleared to receive samples of the virus derived from the first U.S. case of Coronavirus Disease (COVID-19), a 35-year-old man in Snohomish County, Wash., who recovered. Others have ordered the virus and are waiting. Frieman plans to test […]

Masks vs. Respirators: Experts Explain COVID-19 Recommendations

In its newly published infection prevention and control recommendations for COVID-19, the US Centers for Disease Control and Prevention (CDC) recommends the use of N95 respirators in a healthcare setting with the suspected novel coronavirus, but the World Health Organization (WHO) has recommended surgical masks for general patient care and respirators for aerosol-generating procedures only. […]

Coronavirus Disease Naming Announcement Creates Confusion

“COVID-19. I’ll spell it: C-O-V-I-D hyphen one nine. COVID-19.” That’s how Tedros Adhanom Ghebreyesus, head of the World Health Organization (WHO),  introduced the agency’s official name  for the new disease that’s paralyzing China  The christening yesterday, at one of WHO’s outbreak press conferences in Geneva.1 COVID-19 is a name for the disease, not for the […]


PODCASTS + VIDEOS

TWiV 586: Coronavirus Update: Wash Your Hands TWiV team discusses the fatality rate, China’s initial reaction to the outbreak, conspiracy theories, how long the virus remains infectious on surfaces, and evidence for virus in the intestinal tract. This Week in Virology

COVID-19: What’s Happening Now IDSA speaks with Drs. Elisa Choi of Harvard Medical School, Amesh Adalja of Johns Hopkins Center for Health Security & Adeel Butt of Weill Cornell Medicine about the latest COVID-19 response efforts, public risk here and abroad, & the effects of recent travel restrictions. IDSA

Prevention, Protection, and Paediatrics During COVID-19 Dr Shunmay Yeung is a paediatrician who specialises in infectious diseases, and was one of the first LSHTM responders to the Ebola outbreak in 2014. Here, she discusses personal protective equipment (PPE) for healthcare workers during outbreaks, advice for how the public can best protect themselves, and why children don’t seem to be affected by COVID-19. LSHTM Viral

COVID-19 Special Episode with Dr. Jonathan (Jono) Quick, author of The End of Epidemics and Professor at Duke University PDR Podcast

Novel Coronavirus Panel at the Johns Hopkins Bloomberg School of Public Health Johns Hopkins University

The Emerging Role of Pathogen Genomics in Public Health CDC


Journal Watch + Research Updates

High-Throughput Automated Biodosimetry in Response to a Large-Scale Radiological Event

A High Throughput Approach to Reconstruct Partial-Body and Neutron Radiation Exposures on an Individual Basis The need for high-throughput automated biodosimetry in response to a large-scale radiological…

NIH Study Supports New Approach for Treating Cerebral Malaria

Researchers at the National Institutes of Health found evidence that specific immune cells may play a key role in the devastating effects of cerebral malaria, a severe…

Atomic Structures Mapped for First Time in Paramyxoviruses

Northwestern University researchers have, for the first time, determined the 3D atomic structure of a key complex in paramyxoviruses, a family of viruses that includes measles, mumps,…

New Method Predicts Individual Response to Ebola Infection

Not everyone who catches Ebola dies of the hemorrhagic virus infection. Some people mount a robust immune defense and recover fully. Yet risk factors for susceptibility to…

Scientists Find Ally in Fight Against Brain Tumors: Ebola

Glioblastomas are relentless, hard-to-treat, and often lethal brain tumors. Yale scientists have enlisted a most unlikely ally in efforts to treat this form of cancer — elements…

Persons Evaluated for 2019 Novel Coronavirus — United States, January 2020

CDC Morbidity and Mortality Weekly Report (MMWR) On January 17, CDC and the U.S. Department of Homeland Security’s Customs and Border Protection began health screenings at U.S.…

Combining Viral Genomics with Public Health Data Revealed New Details About Mumps Outbreaks

In 2016 and 2017, a surge of mumps cases at Boston-area universities prompted researchers at the Broad Institute of MIT and Harvard to study mumps virus transmission…

The Lancet: Preliminary Evidence Suggest New Coronavirus Cannot Be Passed From Mother to Child Late in Pregnancy

Evidence of intrauterine vertical transmission was assessed by testing for the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, formerly the 2019 novel coronavirus or 2019-nCoV) in amniotic…

Bats’ Fierce Immune Systems Drive Viruses To Higher Virulence, Making Them Deadlier in Humans

A new University of California, Berkeley, study finds that bats’ fierce immune response to viruses could drive viruses to replicate faster, so that when they jump to…


FEATURED EVENTS

Feb 24: CDC National Call Series on Novel Coronavirus Monitoring and Preparedness

CDC’s 2019 Novel Coronavirus (2019-nCoV) response team will host a series of national calls to continue providing state and local partners with the latest information on the novel coronavirus outbreak and U.S. preparedness efforts. Learn more.

Feb 25-26: Developing MCMs to Treat Acute and Chronic Effects of Ocular Chemical Toxicity

A U.S. Trans-Agency Scientific Meeting on Developing Medical Countermeasures to Treat Acute and Chronic Effects of Ocular Chemical Toxicity will be held Feb 25-26, 2020 at the NIAID Conference Center in Rockville, Md. Learn more

Feb 26: Emerging Bioethical Issues in Biomedical Research: A Workshop

A planning committee of the National Academies of Sciences, Engineering, and Medicine will conduct a one day workshop on Feb 26, 2020 to bring together stakeholders to discuss potential ethical issues that may arise from new and emerging trends in biomedical research. Event is also webcast. Learn more.

Feb 29 – Mar 3: 16th CDC International Symposium on Biosafety

The 16th CDC International Symposium on Biosafety – Laboratory Safety and Security for Clinical, Public Health, Research and Animal Care will be held 29 February – 4 March, 2020 in Atlanta, Georgia. Learn more

Mar 2: CDC National Call Series on Novel Coronavirus Monitoring and Preparedness

CDC’s 2019 Novel Coronavirus (2019-nCoV) response team will host a series of national calls to continue providing state and local partners with the latest information on the novel coronavirus outbreak and U.S. preparedness efforts. Learn more.

Mar 3-5: Mitigating the Impact of Blast-related Burn Injuries: From Prolonged Field Care to Rehabilitation and Resilience

The 9th DoD State-of-the-Science Meeting on Blast Injury Research will be held March 3-5, 2020 in Arlington. The meeting will address epidemiology and outcomes of blast-related burn injuries; prevention and acute management of blast-related burn injuries; prolonged field care and chronic care; and transforming research. Learn more REGISTRATION IS FULL

Feb 27: House Foreign Affairs Subcommittee on Asia, the Pacific, and Nonproliferation: Coronavirus Disease 2019: The U.S. and International Response

Officials from the State Department and the CDC Director will testify. Learn more

VIEW ALL EVENTS

Mar 12: Center for the Study of WMD Spotlight Seminar: Coronavirus and Biosecurity

The panel will feature experts in the fields of bioterrorism, biosurveillance, and infectious disease who can provide timely context for the outbreak. Learn more

Mar 18: Next Evolution: Overhauling Key Elements of Biodefense

The Bipartisan Commission on Biodefense will discuss the Federal Select Agent Program, BioWatch, and the Hospital Preparedness Program at this meeting in DC (and webcast). Learn more

Mar 18-19: Joint Civil + DoD CBRN Symposium

An annual gathering of the most respected minds in the CBRN defense community, including operational leaders, intelligence providers, key policymakers and solution providers from Industry and Academia. Register now

Mar 26-30: Decennial 2020 – International Conference on Healthcare Associated Infections

Held once every ten years, the Decennial Conference reviews the advances of the previous decade and the opportunities and trends for the fields of healthcare epidemiology, infectious diseases, and infection prevention and control for the future. Learn more

Mar 31-Apr 3: Preparedness Summit 2020

The NACCHO will host this year’s 2020 Preparedness Summit from 31 March – 3 April 2020 in Dallas, Texas.

Apr 20-24: Achieving Data Quality and Integrity in Maximum Containment Laboratories Training Event

This BSL-4 training event 20-24 April is co-sponsored by the FDA and UTMB Galveston National Lab. Learn more.

May 28-29: Critical Public Health Value of Vaccines in the Age of Pandemics

The National Academies of Sciences, Engineering, and Medicine Board on Global Health will host a 1.5-day public workshop May 28-29 that will examine the current state of vaccine preventable diseases and the impact of vaccine access and hesitancy globally, and the multidimensional drivers and impacts of declining vaccine confidence. Learn more


Sign up to receive weekly insights from the team at Global Biodefense.

Latest News from Global Biodefense

UK Launches Wide-Area Biosensor Competition

UK Launches Wide-Area Biosensor Competition

The Defence and Security Accelerator (DASA) competition is seeking innovative technologies for Phase 2 of a Wide-Area Biosensor program that aims to find an improved…

OraSure Gains BARDA Backing for First Rapid COVID-19 Home Testing Kit

OraSure Gains BARDA Backing for First Rapid COVID-19 Home Testing Kit

BARDA and OraSure Technology, Inc. are working together on the development of a point-of-care (POC) test for SARS-CoV-2 that could bring testing closer to the patient.…

FDA-ARGOS SARS-CoV-2 Reference Grade Sequence Data Now Available

FDA-ARGOS SARS-CoV-2 Reference Grade Sequence Data Now Available

In response to the COVID-19 pandemic, the FDA—in collaboration with the Centers for Disease Control and Prevention (CDC), the Biodefense and Emerging Infections Research Resources…

Designing Face Shields to Protect Medical Staff During Critical Supply Shortages

Designing Face Shields to Protect Medical Staff During Critical Supply Shortages

The COVID-19 pandemic has created an unprecedented need to provide personal protective equipment (PPE) for hospital staff. A team of Montreal medical experts has partnered…

Tests in Engineered Human Tissues Show hrsACE2 Drug Blocked Early Stages of SARS-CoV-2 Infection

Tests in Engineered Human Tissues Show hrsACE2 Drug Blocked Early Stages of SARS-CoV-2 Infection

An international team led by University of British Columbia researcher Dr. Josef Penninger has found a trial drug that effectively blocks the cellular door SARS-CoV-2…

JPEO-CBRND, BARDA Partner with SAb Biotherapeutics to Develop COVID-19 Therapeutic

JPEO-CBRND, BARDA Partner with SAb Biotherapeutics to Develop COVID-19 Therapeutic

A therapeutic to treat novel coronavirus disease 2019 (COVID-19) is moving forward in development through a partnership announced Apr. 1 between BARDA, the Department of Defense…

Health Security Today – 1 April 2020

Health Security Today – 1 April 2020

FEATURED FDA, NIH, Veteran Affairs Partner with America Makes for 3D Printing Innovations During Pandemic Response Through this collaboration, the U.S. government and partners will…

USAMRIID Resumes Full Operations Following Federal Select Agent Program Reinstatement

USAMRIID Resumes Full Operations Following Federal Select Agent Program Reinstatement

Researchers at the U.S. Army Medical Research Institute of Infectious Diseases continue to work on medical countermeasures for the novel coronavirus as part of the…

Diagnostic Hoax: FDA Has Not Announced EUA for Bodysphere 2-Min Test

Diagnostic Hoax: FDA Has Not Announced EUA for Bodysphere 2-Min Test

Reuters published a short report based on a poorly written press release on BusinessWire (since removed) from an unverified company claiming to have received an…

Preventing COVID-19 From Overtaking Nursing Homes Requires Spending Money and Improving Infection Control

Preventing COVID-19 From Overtaking Nursing Homes Requires Spending Money and Improving Infection Control

At least 11 people have died from COVID-19 in New Orleans nursing homes in the past week, just after the deaths at a Seattle nursing…

Cue Health Awarded Federal Contract for 25-Minute Nasal Swab COVID-19 Test

Cue Health Awarded Federal Contract for 25-Minute Nasal Swab COVID-19 Test

The Biomedical Advanced Research and Development Authority (BARDA) and Cue Health will collaborate under a new contract announced today to accelerate the development, validation, and…

Duke Starts Innovative Decon of N95 Masks Using Vaporized Hydrogen Peroxide to Alleviate Shortages

Duke Starts Innovative Decon of N95 Masks Using Vaporized Hydrogen Peroxide to Alleviate Shortages

Facing a critical shortage of N95 face masks that block the coronavirus, Duke Health research and clinical teams have confirmed a way to use existing…